David Chen
0009-0007-5537-9096
Publication & Citation Trends
Publications
0 total
PD15-10 OUTCOMES FOR PATIENTS UNDERGOING SPACEOAR PLACEMENT IN THE SALVAGE RADIATION THERAPY SETTING
Cited by 0
Semantic Scholar
Correction: Candidate variants in DNA replication and repair genes in early-onset renal cell carcinoma patients referred for germline testing OA
Cited by 1
Semantic Scholar
A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study. OA
Cited by 50
Semantic Scholar
A phase II trial of risk-enabled therapy after initiating neoadjuvant chemotherapy for bladder cancer (RETAIN).
Cited by 31
Semantic Scholar
Association of tumor size and surgical approach with oncological outcomes and overall survival in patients with adrenocortical carcinoma.
Cited by 4
Semantic Scholar
Long Term Results of a Phase III Randomized Prospective Trial of Erectile Tissue Sparing IMRT for Men with Clinically Localized Prostate Cancer. OA
Cited by 15
Semantic Scholar
No difference in renal function outcomes for patients with oncocytoma managed with active surveillance vs. partial nephrectomy. OA
Cited by 3
Semantic Scholar
Association of Surgical Approach With Treatment Burden, Oncological Effectiveness, and Perioperative Morbidity in Adrenocortical Carcinoma. OA
Cited by 5
Semantic Scholar
Research Topics
Renal cell carcinoma treatment
(52)
Lung Cancer Treatments and Mutations
(32)
Renal and related cancers
(28)
Bladder and Urothelial Cancer Treatments
(26)
Advanced Breast Cancer Therapies
(25)
Affiliations
Roche (Switzerland)
Australian National University
Novartis (Switzerland)
Fox Chase Cancer Center
Center for Global Development